Hospital transplant departments have strict cutoffs for patients with higher body mass indexes because of the increased risk of complications, but GLP-1s such as Ozempic and Wegovy are helping more patients be eligible for surgery.
GLP-1s
Counterfeit versions of Novo Nordisk's Ozempic are becoming more of a concern, both for the company and to global authorities. Lars Fruergaard Jørgensen, the Danish drugmaker's CEO, told Reuter's the company is currently working alongside authorities in multiple countries to…
Citing high costs and low medication adherence, self-insured employers nationwide are making moves to end or limit coverage for employees prescribed weight loss medications, including major health systems.
New York City Councilwoman Julie Menin introduced a bill March 7 that would require the city's Commissioner of Health and Mental Hygiene to create and distribute materials about the possible negative health effects from prescribing and using prescription drugs for their…
After finding success in the emerging sector of semaglutide drugs, Novo Nordisk's latest work toward development of it in pill form has shown results that are even better than Wegovy when it comes to shedding weight.
Advertisement
Physicians are reportedly seeing an increasing number of patients who have used anti-obesity drugs like Ozempic and Wegovy request procedures to remove sagging, excess skin via plastic surgery, KDVR reported Feb. 23.
Morgantown, W.Va.-based WVU Medicine is piloting an obesity management treatment program for eligible employees and covered family members.
This episode features Jakob Emerson, Insurance Editor at Becker's Healthcare. Here, he discusses how medicaid redeterminations are going across the country and the coverage of new weight loss drugs such as Ozempic.
A method for predicting which ovarian cancer patients are unlikely to benefit from chemotherapy was discovered by researchers from the Icahn School of Medicine at Mount Sinai in New York City, according to a study published in Cell Aug. 3.
This episode features Jason McGrath, President of BeScreened. Here, he discusses his personal battle with colon cancer and how it inspired him to be a colon cancer screening advocate in order to catch cancer as early as possible, saving as…